Breast Cancer Cell Density: Imaging assay of the density- and context-dependence of small molecule perturbagen response in breast cancer cell lines. Dataset 1 of 3: Cell count and normalized growth rate inhibition values. - Dataset (ID:20256)
Download: Excel (XLSX), Comma-separated (CSV)
| Cell | Small Molecule | Small Mol Concentration | Small Mol Conc Unit | Replicate | Seeding Density | Total Cell Count Before Treatment | Total Cell Count After Treatment | Total Control Cell Count | Relative Cell Count | Normalized Growth Rate Inhibition Value |
|---|---|---|---|---|---|---|---|---|---|---|
| SK-BR-3 | Erlotinib | 0.0033113 | uM | 7 | 5000.00 | 1699.69 | 5574.00 | 5493.00 | 1.0147 | 1.0174 |
| SK-BR-3 | Lapatinib | 10 | uM | 7 | 5000.00 | 1699.69 | 3321.00 | 5493.00 | 0.6046 | 0.4856 |
| SK-BR-3 | Linsitinib | 0.0033113 | uM | 7 | 5000.00 | 1699.69 | 5665.00 | 5493.00 | 1.0313 | 1.0368 |
| SK-BR-3 | Erlotinib | 3.1623 | uM | 7 | 5000.00 | 1699.69 | 5232.00 | 5493.00 | 0.9525 | 0.9433 |
| SK-BR-3 | Lapatinib | 1 | uM | 7 | 5000.00 | 1699.69 | 3581.00 | 5493.00 | 0.6519 | 0.5532 |
| SK-BR-3 | Lapatinib | 0.31623 | uM | 7 | 5000.00 | 1699.69 | 3566.00 | 5493.00 | 0.6492 | 0.5494 |
| SK-BR-3 | Erlotinib | 10 | uM | 7 | 5000.00 | 1699.69 | 3415.00 | 5493.00 | 0.6217 | 0.5103 |
| SK-BR-3 | Erlotinib | 19.9526 | uM | 7 | 5000.00 | 1699.69 | 3305.00 | 5493.00 | 0.6017 | 0.4813 |
| SK-BR-3 | 17-AAG | 0.0016596 | uM | 7 | 5000.00 | 1699.69 | 5728.00 | 5493.00 | 1.0428 | 1.0501 |
| SK-BR-3 | 17-AAG | 10 | uM | 7 | 5000.00 | 1699.69 | 3182.00 | 5493.00 | 0.5793 | 0.4485 |
| SK-BR-3 | Linsitinib | 0.01 | uM | 7 | 5000.00 | 1699.69 | 5744.00 | 5493.00 | 1.0457 | 1.0535 |
| SK-BR-3 | 0 | uM | 7 | 5000.00 | 1699.69 | 5613.00 | 5493.00 | 1.0218 | 1.0257 | |
| SK-BR-3 | Linsitinib | 10 | uM | 7 | 5000.00 | 1699.69 | 4488.00 | 5493.00 | 0.8170 | 0.7749 |
| SK-BR-3 | Linsitinib | 19.9526 | uM | 7 | 5000.00 | 1699.69 | 3917.00 | 5493.00 | 0.7131 | 0.6378 |
| SK-BR-3 | Erlotinib | 0.31623 | uM | 7 | 5000.00 | 1699.69 | 5749.00 | 5493.00 | 1.0466 | 1.0546 |
| SK-BR-3 | 17-AAG | 0.0033113 | uM | 7 | 5000.00 | 1699.69 | 5510.00 | 5493.00 | 1.0031 | 1.0037 |
| SK-BR-3 | 0 | uM | 7 | 5000.00 | 1699.69 | 5488.00 | 5493.00 | 0.9991 | 0.9989 | |
| SK-BR-3 | 0 | uM | 7 | 5000.00 | 1699.69 | 5674.00 | 5493.00 | 1.0330 | 1.0387 | |
| SK-BR-3 | 0 | uM | 7 | 5000.00 | 1699.69 | 0.00 | 5493.00 | 0.0000 | -1.0000 | |
| SK-BR-3 | 0 | uM | 7 | 5000.00 | 1699.69 | 3.00 | 5493.00 | 0.0005 | -0.9764 | |
| SK-BR-3 | 0 | uM | 7 | 5000.00 | 1699.69 | 3957.00 | 5493.00 | 0.7204 | 0.6476 | |
| SK-BR-3 | 17-AAG | 0.01 | uM | 7 | 5000.00 | 1699.69 | 3113.00 | 5493.00 | 0.5667 | 0.4299 |
| SK-BR-3 | 17-AAG | 0.31623 | uM | 7 | 5000.00 | 1699.69 | 2194.00 | 5493.00 | 0.3994 | 0.1628 |
| SK-BR-3 | 17-AAG | 0.1 | uM | 7 | 5000.00 | 1699.69 | 2311.00 | 5493.00 | 0.4207 | 0.1991 |
| SK-BR-3 | Erlotinib | 0.031623 | uM | 7 | 5000.00 | 1699.69 | 4643.00 | 5493.00 | 0.8453 | 0.8109 |